PT CKD OTTO Pharmaceuticals has been preparing to build production facilities for lyophilized powder injection and liquid injection since 2016 located in Delta Silicon 3 Industrial Estate Cikarang, marked by the Ground Breaking Ceremony on July 25th, 2016. The production facilities of PT CKD OTTO Pharmaceuticals have been designed to meet the criteria for Good Manufacturing Practice (GMP). In approximately two years since construction, in September 2018 PT CKD OTTO Pharmaceuticals has received a GMP certificate issued by the National Agency of Drug and Food Control (BPOM) in September 2018 after going through an audit process by BPOM. With its GMP certificate, PT CKD OTTO Pharmaceuticals has met the requirements and criteria for lyophilized powder injection and liquid injection. PT CKD OTTO Pharmaceutical is also committed to continuing to maintain the quality of the products produced in order to provide quality products to patients.